|
Nuvalent Inc-a
(NUVL)
|
22.2 |
$2.1B |
|
17M |
123.50 |
|
Brookdale Sr Living Note 3.500%10/1 (Principal)
|
6.1 |
$586M |
|
307M |
1.91 |
|
Revolution Medicines
(RVMD)
|
4.7 |
$448M |
|
2.4M |
187.28 |
|
Praxis Precision Medicines I Com New
(PRAX)
|
3.4 |
$323M |
|
963k |
334.79 |
|
Viatris
(VTRS)
|
3.3 |
$321M |
|
20M |
15.88 |
|
Centene Corporation
(CNC)
|
3.3 |
$315M |
|
4.9M |
64.19 |
|
Revolution Medicines Note 0.500% 5/0 (Principal)
|
2.6 |
$252M |
|
200M |
1.26 |
|
United Therapeutics Corporation
(UTHR)
|
2.6 |
$248M |
|
457k |
541.83 |
|
Arrowhead Pharmaceuticals In Note 1/1 (Principal)
|
2.5 |
$241M |
|
200M |
1.20 |
|
Legend Biotech Corp Sponsored Ads
(LEGN)
|
2.5 |
$235M |
|
8.1M |
28.88 |
|
Cogent Biosciences
(COGT)
|
2.0 |
$194M |
|
5.0M |
38.70 |
|
Genmab A/s Sponsored Ads
(GMAB)
|
2.0 |
$189M |
|
6.9M |
27.47 |
|
Brookdale Senior Living
(BKD)
|
2.0 |
$187M |
|
12M |
16.09 |
|
Vera Therapeutics Cl A
(VERA)
|
1.8 |
$168M |
|
3.9M |
42.91 |
|
Ionis Pharmaceuticals
(IONS)
|
1.6 |
$157M |
|
2.0M |
79.29 |
|
Celcuity
(CELC)
|
1.6 |
$152M |
|
1.5M |
104.62 |
|
BioCryst Pharmaceuticals
(BCRX)
|
1.6 |
$151M |
|
15M |
10.00 |
|
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
1.5 |
$145M |
|
4.3M |
33.89 |
|
Acadia Healthcare
(ACHC)
|
1.4 |
$134M |
|
4.5M |
29.53 |
|
Tango Therapeutics
(TNGX)
|
1.4 |
$131M |
|
4.2M |
31.26 |
|
Adapthealth Corp Common Stock
(AHCO)
|
1.2 |
$120M |
|
12M |
10.42 |
|
Pharvaris N V
(PHVS)
|
1.2 |
$117M |
|
3.4M |
34.58 |
|
Celcuity Note 0.250% 8/0 (Principal)
|
1.2 |
$114M |
|
100M |
1.14 |
|
Arrowhead Pharmaceuticals
(ARWR)
|
1.2 |
$113M |
|
1.4M |
81.51 |
|
Dianthus Therapeutics
(DNTH)
|
1.1 |
$110M |
|
1.1M |
97.48 |
|
Larimar Therapeutics
(LRMR)
|
1.1 |
$109M |
|
36M |
3.05 |
|
Mineralys Therapeutics
(MLYS)
|
1.1 |
$107M |
|
4.0M |
26.98 |
|
Alignment Healthcare Note 4.250%11/1 (Principal)
|
1.1 |
$104M |
|
61M |
1.70 |
|
Ideaya Biosciences
(IDYA)
|
1.1 |
$101M |
|
2.7M |
37.27 |
|
Xenon Pharmaceuticals
(XENE)
|
1.0 |
$98M |
|
1.6M |
60.36 |
|
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
|
1.0 |
$93M |
|
60M |
1.55 |
|
Savara
(SVRA)
|
0.9 |
$84M |
|
14M |
6.16 |
|
Lantheus Holdings Inc Common Stock Usd 0.01
(LNTH)
|
0.9 |
$84M |
|
753k |
110.94 |
|
Syndax Pharmaceuticals
(SNDX)
|
0.9 |
$83M |
|
3.8M |
21.86 |
|
Zenas Biopharma Note 2.500% 4/0 (Principal)
|
0.8 |
$80M |
|
67M |
1.20 |
|
BioMarin Pharmaceutical
(BMRN)
|
0.8 |
$76M |
|
1.3M |
57.22 |
|
Pfizer
(PFE)
|
0.8 |
$73M |
|
3.0M |
24.08 |
|
Indivior Pharmaceuticals
(INDV)
|
0.7 |
$68M |
|
1.6M |
41.03 |
|
Bio Rad Labs Cl A
(BIO)
|
0.7 |
$66M |
|
226k |
293.61 |
|
Silverback Therapeutics
(SPRY)
|
0.6 |
$60M |
|
7.5M |
8.01 |
|
Stoke Therapeutics
(STOK)
|
0.6 |
$60M |
|
1.8M |
32.72 |
|
Structure Therapeutics Sponsored Ads
(GPCR)
|
0.6 |
$58M |
|
1.1M |
53.67 |
|
Envista Hldgs Corp
(NVST)
|
0.6 |
$58M |
|
2.2M |
26.35 |
|
Inspire Med Sys
(INSP)
|
0.6 |
$58M |
|
1.3M |
44.61 |
|
Caredx
(CDNA)
|
0.6 |
$57M |
|
2.0M |
28.50 |
|
Boston Scientific Corporation
(BSX)
|
0.6 |
$56M |
|
1.3M |
42.68 |
|
Belite Bio Sponsored Ads
(BLTE)
|
0.6 |
$55M |
|
357k |
153.99 |
|
Parabilis Medicines
|
0.5 |
$52M |
|
1.9M |
27.37 |
|
Certara Ord
(CERT)
|
0.5 |
$49M |
|
7.5M |
6.55 |
|
Disc Medicine
(IRON)
|
0.5 |
$48M |
|
657k |
73.14 |
|
Livanova Note 2.500% 3/1 (Principal)
|
0.5 |
$47M |
|
34M |
1.36 |
|
Bridgebio Oncology Therapeut Com New
(BBOT)
|
0.4 |
$37M |
|
4.9M |
7.62 |
|
Tyra Biosciences
(TYRA)
|
0.3 |
$33M |
|
1.0M |
31.94 |
|
Monopar Therapeutics Com New
(MNPR)
|
0.3 |
$30M |
|
324k |
92.59 |
|
Sionna Therapeutics
(SION)
|
0.3 |
$30M |
|
681k |
43.99 |
|
Immunocore Hldgs Note 2.500% 2/0 (Principal)
|
0.3 |
$27M |
|
30M |
0.90 |
|
Avalyn Pharmaceuticals Com Shs
|
0.3 |
$24M |
|
731k |
32.92 |
|
Foghorn Therapeutics
(FHTX)
|
0.2 |
$21M |
|
4.4M |
4.88 |
|
Beta Bionics
(BBNX)
|
0.2 |
$21M |
|
1.3M |
15.67 |
|
Alnylam Pharmaceuticals
(ALNY)
|
0.2 |
$21M |
|
68k |
301.03 |
|
Bright Minds Biosciences Com New
(DRUG)
|
0.2 |
$20M |
|
283k |
70.20 |
|
Odyssey Therapeutics Common Stock
|
0.2 |
$20M |
|
1.0M |
18.71 |
|
Oncology Institu
(TOI)
|
0.2 |
$18M |
|
3.4M |
5.43 |
|
Kyverna Therapeutics
(KYTX)
|
0.2 |
$18M |
|
2.0M |
8.91 |
|
Alamar Biosciences Common Stock
|
0.2 |
$16M |
|
600k |
27.09 |
|
Chemed Corp Com Stk
(CHE)
|
0.1 |
$14M |
|
30k |
465.74 |
|
Spyglass Pharma Com Shs
(SGP)
|
0.1 |
$12M |
|
550k |
22.26 |
|
Neogenomics Note 0.250% 1/1 (Principal)
|
0.1 |
$12M |
|
13M |
0.94 |
|
Adagene Ads
(ADAG)
|
0.1 |
$11M |
|
2.7M |
4.20 |
|
Hemab Therapeutics Hldgs Com Shs
|
0.1 |
$10M |
|
275k |
36.73 |
|
Mobia Med Common Stock
|
0.1 |
$9.0M |
|
671k |
13.40 |
|
Embecta Corp Common Stock
(EMBC)
|
0.1 |
$8.3M |
|
2.5M |
3.26 |
|
Veracyte
(VCYT)
|
0.1 |
$5.9M |
|
101k |
58.73 |
|
Annexon
(ANNX)
|
0.0 |
$3.3M |
|
584k |
5.71 |
|
Alector
(ALEC)
|
0.0 |
$2.1M |
|
1.1M |
2.01 |
|
Newamsterdam Pharma Company *w Exp 99/99/999
(NAMSW)
|
0.0 |
$2.0M |
|
93k |
21.37 |
|
Edwards Lifesciences
(EW)
|
0.0 |
$1.2M |
|
14k |
90.46 |
|
Mirum Pharmaceuticals
(MIRM)
|
0.0 |
$706k |
|
6.0k |
117.07 |
|
Humana
(HUM)
|
0.0 |
$364k |
|
917.00 |
397.22 |
|
The Oncology Institute *w Exp 99/99/999
(TOIIW)
|
0.0 |
$51k |
|
1.3M |
0.04 |
|
Pmv Pharmaceuticals
(PMVP)
|
0.0 |
$12k |
|
8.8k |
1.34 |
|
Surrozen *w Exp 08/01/203
(SRZNW)
|
0.0 |
$2.7k |
|
167k |
0.02 |